Anton E. Coleman
Impact in
- Psychiatry and Mental health top 5%
- Epilepsy research and treatment
- Sexual function and dysfunction studies
- Biochemistry top 5%
- Amino Acid Enzymes and Metabolism
Papers in
-
- Amino Acid Enzymes and Metabolism 2
-
- Epilepsy research and treatment 2
- Dementia and Cognitive Impairment Research 1
- Co-authors
- Andrew G. Herzog (4 shared papers)Frank W. Drislane (3 shared papers)Donald L. Schomer (3 shared papers)Alan Roy Jacobs (3 shared papers)Arthur J.L. Cooper (2 shared papers)Eric Nieves (1 shared paper)Alan S. Gelbard (1 shared paper)Mark Friedman (2 shared papers)
- Journals
- Neurology (2 papers)Annals of Neurology (2 papers)Hepatology (1 paper)Journal of Neurochemistry (1 paper)Epilepsy & Behavior (1 paper)
- Partner nations
- United StatesArgentina
In The Last Decade
Anton E. Coleman
12 papers receiving 484 citations
Peers
Comparison fields: 5 of 59
- Psychiatry and Mental health 215
- Biochemistry 71
- Pediatrics, Perinatology and Child Health 106
- Reproductive Medicine 66
- Clinical Biochemistry 21
Countries citing papers authored by Anton E. Coleman
This map shows the geographic impact of Anton E. Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton E. Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton E. Coleman more than expected).
Fields of papers citing papers by Anton E. Coleman
This network shows the impact of papers produced by Anton E. Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton E. Coleman. The network helps show where Anton E. Coleman may publish in the future.
Co-authors
The 25 scholars most cited alongside Anton E. Coleman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 111 | |
| 2 | 2003 | 102 | |
| 3 | 1994 | 92 | |
| 4 | 2003 | 62 | |
| 5 | 2000 | 53 | |
| 6 | 1999 | 30 | |
| 7 | 1990 | 23 | |
| 8 | 1989 | 19 | |
| 9 | 1992 | 14 | |
| 10 | 2006 | 9 | |
| 11 | 1987 | 5 | |
| 12 | Thalidomide Should Be Tested as a Therapeutic Option in COVID-19 Pneumonia. | 2020 | 1 |
About Anton E. Coleman
Anton E. Coleman is a scholar working on Biochemistry, Psychiatry and Mental health, Clinical Biochemistry, Neurology and Transplantation, having authored 12 papers that have together received 521 indexed citations. Recurring topics across this work include Epilepsy research and treatment (2 papers), Metabolism and Genetic Disorders (2 papers), Amino Acid Enzymes and Metabolism (2 papers), Hypothalamic control of reproductive hormones (1 paper), Autoimmune Neurological Disorders and Treatments (1 paper), Alzheimer's disease research and treatments (1 paper), Dementia and Cognitive Impairment Research (1 paper) and COVID-19 Clinical Research Studies (1 paper). The work is most often cited by research in Psychiatry and Mental health (215 citations), Biochemistry (71 citations), Pediatrics, Perinatology and Child Health (106 citations), Reproductive Medicine (66 citations) and Clinical Biochemistry (21 citations). Anton E. Coleman has collaborated with scholars based in United States and Argentina. Frequent co-authors include Andrew G. Herzog, Frank W. Drislane, Donald L. Schomer, Alan Roy Jacobs, Arthur J.L. Cooper, Eric Nieves, Alan S. Gelbard, Mark Friedman, Pavel Klein and Adrián L. Rabinowicz. Their work appears in journals such as Neurology, Annals of Neurology, Hepatology, Journal of Neurochemistry and Epilepsy & Behavior.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.